CME Adds Bitcoin Cash and Uniswap Futures, Targeting October 19 Launch

CME Group is bringing Bitcoin Cash and Uniswap futures to its regulated derivatives platform next month, extending a crypto product buildout that began with Bitcoin futures in December 2017.

The exchange announced both standard and micro-sized contracts for each asset. Bitcoin Cash futures will come in 250 BCH (standard) and 25 BCH (micro) denominations. Uniswap futures follow the same two-tier structure: 10,000 UNI for standard contracts and 1,000 UNI for micro. Both products go live October 19, pending regulatory review.

The micro contract sizing is deliberate. Smaller notional values lower the capital barrier for institutional desks running hedges or testing exposure before committing full position sizes. CME used the same playbook when it introduced Micro Bitcoin futures in May 2021, a product that attracted prop trading firms and smaller funds that found the standard 5 BTC contract too blunt an instrument.

CME's crypto derivatives business is not a side project. The exchange reported $8.3 billion in average daily volume across its crypto derivatives suite in H1 2026, a figure that reflects sustained institutional appetite for regulated, centrally cleared exposure rather than the counterparty risk that comes with offshore venues. That volume base gives CME real leverage when pitching new listings: liquidity begets liquidity, and compliance teams at asset managers can clear CME products without the legal gymnastics required for unregulated alternatives. For context, institutional traders have been aggressively positioning in CME's Bitcoin options market, with $3.2 million in bets placed on Bitcoin reaching $95,000 by October alone.

The choice of BCH and UNI as the next listings warrants scrutiny. Bitcoin Cash is a proof-of-work chain with a long enough track record and sufficient spot market liquidity to support a credible futures market. Uniswap is different: UNI is a governance token for the leading decentralized exchange by volume, and adding it to CME's roster implicitly signals that regulators and the exchange are comfortable treating it as a commodity derivative rather than a security. That distinction matters enormously. Any futures contract on UNI that implied it was a security would be a regulatory minefield. CME listing it suggests the exchange's legal team has reached a comfortable conclusion on that question, which could have downstream effects on how other DeFi-adjacent tokens are classified.

Not everyone is buying the growth narrative. CME's stock fell on the announcement, a sign that equity markets are skeptical the new listings will move the needle on near-term revenue. The concern is defensible: BCH and UNI are not Bitcoin or Ethereum, and institutional demand for derivatives on mid-cap crypto assets is unproven at CME's venue. Competition is also tightening. Nasdaq and other regulated venues have been expanding crypto derivatives capabilities, and the market for compliant crypto exposure is no longer CME's alone to capture.

Still, the structural argument for this expansion is straightforward. CME does not need BCH or UNI futures to immediately print volume records. It needs to be the venue where institutional capital goes when it wants regulated exposure to the broader crypto market, not just the top two assets. Adding depth to the product suite builds that positioning over time, even if individual contracts start slow.

The October 19 launch date gives market makers roughly four weeks to set up infrastructure and prime liquidity. Whether that is enough runway to avoid a thin-book opening will depend on how many desks show up ready to trade on day one.